How to Trip Rapid Review
Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)
Step 2: press
Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.
- 5,188 results
- Evidence type
- Clinical Area
Use check boxes to select individual results below
SmartSearch available
Trip's SmartSearch engine has discovered connected searches & results. Click to show301. COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response
reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 4 of 111 1 Communicating with patients and minimising Communicating with patients and minimising risk risk 1.1 Communicate with patients, their families and carers, and support their mental wellbeing to help alleviate any anxiety and fear they may have about COVID-19. Signpost to charities (such as Crohn's & Colitis UK, the British Liver Trust, the Crohn's in Childhood Research Association
2020 National Institute for Health and Clinical Excellence - Clinical Guidelines
302. COVID 19 rapid guideline: renal transplantation
Communication and minimising risk Communication and minimising risk 6.1 Communicate with patients, potential living donors, their families and carers, and support their mental wellbeing to help alleviate any anxiety they may have about COVID-19. Signpost to sources of information, support groups (including NHS Volunteer Responders) and government guidance. For example: • UK government guidance on the mental health and wellbeing aspects of COVID-19 • Kidney Care UK COVID-19 guidance for patients with kidney
2020 National Institute for Health and Clinical Excellence - Clinical Guidelines
303. COVID-19 rapid guideline: community-based care of patients with chronic obstructive pulmonary disease (COPD)
guideline: community-based care of patients with chronic obstructive pulmonary disease (COPD) (NG168) © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 4 of 131 1 Communicating with patients and minimising Communicating with patients and minimising risk risk 1.1 Communicate with patients, their families and carers, and support their mental health and wellbeing to help alleviate any anxiety and fear they may have about (...) is as stable as possible. This includes those with COVID-19, or who are suspected of having it. Keep their self-management plan up to date, and remind them that online video resources on correct inhaler technique are available. 2.2 At every interaction with a patient, be alert for new or increased issues with mental health and wellbeing, particularly anxiety and depression. 2.3 Find out if patients have advance care plans or advance decisions around ceilings of care, including 'do not attempt
2020 National Institute for Health and Clinical Excellence - Clinical Guidelines
304. COVID-19 rapid guideline: dermatological conditions treated with drugs affecting the immune response
) © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 4 of 131 1 Communicating with patients and minimising Communicating with patients and minimising risk risk 1.1 Communicate with patients, their families and carers, and support their mental health and wellbeing to help alleviate any anxiety and fear they may have about COVID-19. Signpost to sources of online information (such as the British Association
2020 National Institute for Health and Clinical Excellence - Clinical Guidelines
305. COVID-19 rapid guideline: cystic fibrosis
the recommendations as the knowledge base and expert experience develops. COVID-19 rapid guideline: cystic fibrosis (NG170) © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 4 of 111 1 Communicating with patients and minimising Communicating with patients and minimising risk risk 1.1 Communicate with patients, their families and carers, and support their mental health and wellbeing to help alleviate any anxiety and fear they may
2020 National Institute for Health and Clinical Excellence - Clinical Guidelines
306. COVID-19 rapid guideline: delivery of systemic anticancer treatments
and have been verified as far as possible. We will review and update the recommendations as the knowledge base and expert experience develops. © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 4 of 131 1 Communicating with patients Communicating with patients 1.1 Communicate with patients and support their mental wellbeing, signposting to charities and support groups where available, to help alleviate any anxiety
2020 National Institute for Health and Clinical Excellence - Clinical Guidelines
307. COVID-19 rapid guideline: dialysis service delivery
reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 4 of 171 1 Communicating with patients Communicating with patients 1.1 Communicate with patients and support their mental wellbeing to help alleviate any anxiety and fear they may have about COVID-19. Point them to resources such as Kidney Care UK. 1.2 T ell patients to alert their dialysis unit if they are unwell. Ask them and their carers to report COVID-19 relevant symptoms before leaving
2020 National Institute for Health and Clinical Excellence - Clinical Guidelines
308. COVID-19 rapid guideline: delivery of radiotherapy
, signposting to charities and support groups (including NHS volunteers) where available, to help alleviate any anxiety and fear they may have about COVID-19. 1.2 Minimise face-to-face contact by: • offering telephone or video consultations whenever possible • cutting non-essential face-to-face follow up, and minimising the number of on-treatment reviews • using alternative ways of delivering medicines, such as postal services, NHS volunteers, or drive-through pick-up points • using local services for blood
2020 National Institute for Health and Clinical Excellence - Clinical Guidelines
309. Colorectal cancer
treatments for colorectal cancer information about possible short-term, long-term, permanent and late side effects which can affect quality of life, including: pain altered bowel, urinary or sexual function nerve damage and neuropathy mental and emotional changes, including anxiety, depression, chemotherapy-related cognitive impairment, and changes to self-perception and social identity. Colorectal cancer (NG151) © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms
2020 National Institute for Health and Clinical Excellence - Clinical Guidelines
310. COVID-19 rapid guideline: severe asthma
Foundation) to help alleviate any anxiety and fear they may have about COVID-19. 1.2 Be aware that severe asthma is defined by the European Respiratory Society and American Thoracic Society as asthma that requires treatment with high- dose inhaled corticosteroids (see inhaled corticosteroid doses for NICE's asthma guideline) plus a second controller (and/or systemic corticosteroids) to prevent it from becoming 'uncontrolled' , or which remains 'uncontrolled' despite this therapy. 1.3 Some patients
2020 National Institute for Health and Clinical Excellence - Clinical Guidelines
311. COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders
and support groups (such as ARMA, which has a list of relevant organisations, and NHS Volunteer Responders) where available, to help alleviate any anxiety and fear they may have about COVID-19. 1.2 Minimise face-to-face contact by: • cutting non-essential face-to-face consultations • offering telephone or video consultations • contacting patients via text message or email • making use of departmental pages on local NHS trust websites • using rheumatology department advice services, including out-of-hours
2020 National Institute for Health and Clinical Excellence - Clinical Guidelines
312. COVID-19 rapid guideline: managing suspected or confirmed pneumonia in adults in the community
to contact. 1.2 Support patients' mental wellbeing, signposting to charities and support groups (including NHS volunteers) where available, to help alleviate any anxiety and fear they may have about COVID-19. 1.3 Minimise face-to-face contact by: • offering telephone or video consultations (see the BMJ guidance on COVID-19: a remote assessment in primary care for a useful guide, including a visual summary for remote consultations) • cutting non-essential face-to-face follow-up • using electronic rather (...) of hospital admission include improved diagnostic tests (chest X-ray, microbiological tests and blood tests) and respiratory support • the risks and disadvantages of hospital admission include spreading or catching COVID-19 and loss of contact with families. Managing breathlessness Managing breathlessness 4.4 Be aware that severe breathlessness often causes anxiety, which can then increase breathlessness further. See the NICE COVID-19 rapid guideline on managing symptoms (including at the end of life
2020 National Institute for Health and Clinical Excellence - Clinical Guidelines
313. COVID-19 rapid guideline: managing symptoms (including at the end of life) in the community
-and- conditions#notice-of-rights). Page 2 of 19Contents Contents Overview 4 1 Communicating with patients and minimising risk 5 2 Treatment and care planning 6 3 General advice for managing COVID-19 symptoms 7 4 Managing cough 8 5 Managing fever 10 6 Managing breathlessness 11 7 Managing anxiety, delirium and agitation 15 8 Managing medicines for patients with COVID-19 17 9 Prescribing anticipatory medicines for patients with COVID-19 18 10 Healthcare workers 19 COVID-19 rapid guideline: managing symptoms (...) ) in the community (NG163) © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 4 of 191 1 Communicating with patients and minimising Communicating with patients and minimising risk risk 1.1 For patients with COVID-19 symptoms explain: • that the key symptoms are cough, fever, breathlessness, anxiety, delirium and agitation but they may also have fatigue, muscle aches and headache • that they and people caring for them should follow
2020 National Institute for Health and Clinical Excellence - Clinical Guidelines
314. COVID-19 rapid guideline: haematopoietic stem cell transplantation
(NG164) © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 5 of 181 1 Communicating with patients and minimising Communicating with patients and minimising risk risk 1.1 Communicate with patients, their families and carers and support their mental wellbeing, signposting to charities and support groups (including NHS volunteers) where available, to help alleviate any anxiety and fear they may have about COVID-19. 1.2
2020 National Institute for Health and Clinical Excellence - Clinical Guidelines
315. KardiaMobile for the ambulatory detection of atrial fibrillation
, and AF diagnosis- related anxiety reduced in 59.6%. Of those responding, 63.8% preferred continued use of KardiaMobile for AF detection. Strengths and limitations Strengths and limitations Authors acknowledge that quality of KardiaMobile ECG recordings may vary in an ambulatory setting, and that algorithm performance may vary in those with lower AF burden. Generalisability may be limited by small sample size and narrow inclusion criteria. Williams et al. (2015) Williams et al. (2015) Study size
2020 National Institute for Health and Clinical Excellence - Advice
316. Dexcom G6 for real-time continuous glucose monitoring
-prick monitoring. Diabetes UK noted the potential benefits of Dexcom on family life because of reducing the diabetes-related anxieties that parents and carers may experience when away from their children. However, the charity also noted that some people using CGM may experience burnout because of alarms or the volume of data CGM can produce. Data from the Dexcom G6 could be used to offer more tailored, person-centred advice and support around steps to improve diabetes self- management. Training
2020 National Institute for Health and Clinical Excellence - Advice
317. Space from Depression for treating adults with depression
, to measure severity of anxiety symptoms. T o compare, the national average starting and finishing PHQ-9 values are shown for people having guided self-help (using books) in IAPT services, and for people having any treatment in IAPT services. Across the 3 services, the change in PHQ-9 values was -3.7 for people who had Space for Depression, compared with -6.6 for people who had standard care. For comparison, the national change in PHQ-9 values for people having guided self-help (using books) was -5.0
2020 National Institute for Health and Clinical Excellence - Advice
318. EarlyCDT-Lung for cancer risk classification of indeterminate pulmonary nodules
such as pneumothorax and bleeding. Two specialists felt that patient exposure to CT scans would be reduced, as well as lessening anxieties over false positive results. Another noted that the early detection of malignant tumour is a potential benefit to the patient. One specialist noted that people with IPN who have comorbidities will benefit from EarlyCDT-Lung. Another felt people in socioeconomically deprived areas will benefit. One specialist noted that it would be interesting to know what effect early detection
2020 National Institute for Health and Clinical Excellence - Advice
319. Volanesorsen for treating familial chylomicronaemia syndrome
of their lives. One patient expert explained that the EQ-5D does not measure the aspects of quality of life that FCS affects, for example, strict adherence to a low- fat diet and the effect of that on their family and social lives. The committee noted that the EQ-5D does not contain questions about difficulties posed by the restricted diet, but does measure usual activities, pain and anxiety. Another patient expert noted that people with FCS may have adapted because living with the condition is their normal
2020 National Institute for Health and Clinical Excellence - Highly specialised technology
320. Testing strategies for Lynch syndrome in people with endometrial cancer
and their families results for both themselves and their families 4.2 There can be considerable anxiety and uncertainty associated with genetic testing for hereditary cancer syndromes such as Lynch syndrome. A patient expert explained that waiting for test results can be a very anxious time. T est results can have a substantial effect on a person, so it is very important that people understand the full implications of a diagnosis of Lynch syndrome, for themselves and their families. This is especially important (...) for people with a T esting strategies for Lynch syndrome in people with endometrial cancer (DG42) © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 18 of 32learning disability, who may need support from a carer to fully engage in discussions about testing and to give informed consent. For people who have not had children yet, or who want more children, there may be anxiety and uncertainty about risk-reducing surgery